Show Search Form
human indexable | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||||||
registered interest | |||||||||||||||||||
answer date | |||||||||||||||||||
date | |||||||||||||||||||
date tabled | |||||||||||||||||||
ddp created | |||||||||||||||||||
answering body |
|
||||||||||||||||||
question status | Tabled | ||||||||||||||||||
answering dept id | 17 | ||||||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||||||
ddp modified |
|
||||||||||||||||||
hansard heading | Measles | ||||||||||||||||||
house id | 1 | ||||||||||||||||||
identifier | 280995 | ||||||||||||||||||
legislature |
|
||||||||||||||||||
parliament number | 57 | ||||||||||||||||||
question first answered |
|
||||||||||||||||||
question text | To ask the Secretary of State for Health and Social Care, what guidance his Department has published on distinguishing between rashes caused by the measles vaccine and those arising from the wild strain of measles. | ||||||||||||||||||
session |
|
||||||||||||||||||
session number | 1 | ||||||||||||||||||
tabling member constituency | Gravesham | ||||||||||||||||||
tabling member printed |
|
||||||||||||||||||
title | House of Commons Tabled Parliamentary Question 2017/19 280995 | ||||||||||||||||||
type |
|
||||||||||||||||||
uin | 280995 | ||||||||||||||||||
version | 2 | ||||||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||||||
answer | answer | ||||||||||||||||||
creator |
|
||||||||||||||||||
publisher | 25259 | ||||||||||||||||||
tabling member | 1522 |
human indexable | |||||||
---|---|---|---|---|---|---|---|
published | |||||||
registered interest | |||||||
answer date | |||||||
date | |||||||
date tabled | |||||||
ddp created | |||||||
answering body |
|
||||||
question status | Tabled | ||||||
answering dept id | 17 | ||||||
answering dept short name | Health and Social Care | ||||||
answering dept sort name | Health and Social Care | ||||||
ddp modified |
|
||||||
hansard heading | Measles | ||||||
house id | 1 | ||||||
identifier | 280996 | ||||||
legislature |
|
||||||
parliament number | 57 | ||||||
question first answered |
|
||||||
question text | To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that statistics on the infection rate for measles do not include people who have received the live measles vaccine and contracted a measles-like rash and fever. | ||||||
session |
|
||||||
session number | 1 | ||||||
tabling member constituency | Gravesham | ||||||
tabling member printed |
|
||||||
title | House of Commons Tabled Parliamentary Question 2017/19 280996 | ||||||
type |
|
||||||
uin | 280996 | ||||||
version | 1 | ||||||
written parliamentary question type | Ordinary | ||||||
answer | answer | ||||||
creator | 1522 | ||||||
publisher | 25259 | ||||||
tabling member | 1522 |
human indexable | |||||||
---|---|---|---|---|---|---|---|
published | |||||||
registered interest | |||||||
answer date | |||||||
date | |||||||
date tabled | |||||||
ddp created | |||||||
answering body |
|
||||||
question status | Tabled | ||||||
answering dept id | 17 | ||||||
answering dept short name | Health and Social Care | ||||||
answering dept sort name | Health and Social Care | ||||||
ddp modified |
|
||||||
hansard heading | MMR Vaccine: Side Effects | ||||||
house id | 1 | ||||||
identifier | 280997 | ||||||
legislature |
|
||||||
parliament number | 57 | ||||||
question first answered |
|
||||||
question text | To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) body inclusion encephalitis and (b) other adverse events experienced after a measles vaccine are identified in a timely way by healthcare professionals. | ||||||
session |
|
||||||
session number | 1 | ||||||
tabling member constituency | Gravesham | ||||||
tabling member printed |
|
||||||
title | House of Commons Tabled Parliamentary Question 2017/19 280997 | ||||||
type |
|
||||||
uin | 280997 | ||||||
version | 1 | ||||||
written parliamentary question type | Ordinary | ||||||
answer | answer | ||||||
creator | 1522 | ||||||
publisher | 25259 | ||||||
tabling member | 1522 |
human indexable | |||||||
---|---|---|---|---|---|---|---|
published | |||||||
registered interest | |||||||
answer date | |||||||
date | |||||||
date tabled | |||||||
ddp created | |||||||
answering body |
|
||||||
question status | Tabled | ||||||
answering dept id | 17 | ||||||
answering dept short name | Health and Social Care | ||||||
answering dept sort name | Health and Social Care | ||||||
ddp modified |
|
||||||
hansard heading | MMR Vaccine: Safety | ||||||
house id | 1 | ||||||
identifier | 280998 | ||||||
legislature |
|
||||||
parliament number | 57 | ||||||
question first answered |
|
||||||
question text | To ask the Secretary of State for Health and Social Care, what steps he is taking to maintain and improve pharmacovigilance in relation to the MMR vaccine. | ||||||
session |
|
||||||
session number | 1 | ||||||
tabling member constituency | Gravesham | ||||||
tabling member printed |
|
||||||
title | House of Commons Tabled Parliamentary Question 2017/19 280998 | ||||||
type |
|
||||||
uin | 280998 | ||||||
version | 1 | ||||||
written parliamentary question type | Ordinary | ||||||
answer | answer | ||||||
creator | 1522 | ||||||
publisher | 25259 | ||||||
tabling member | 1522 |
human indexable | |||||||
---|---|---|---|---|---|---|---|
published | |||||||
registered interest | |||||||
answer date | |||||||
date | |||||||
date tabled | |||||||
ddp created | |||||||
answering body |
|
||||||
question status | Tabled | ||||||
answering dept id | 17 | ||||||
answering dept short name | Health and Social Care | ||||||
answering dept sort name | Health and Social Care | ||||||
ddp modified |
|
||||||
hansard heading | MMR Vaccine | ||||||
house id | 1 | ||||||
identifier | 280999 | ||||||
legislature |
|
||||||
parliament number | 57 | ||||||
question first answered |
|
||||||
question text | To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure (a) transparency and (b) accountability in the process of manufacturing the MMR vaccine. | ||||||
session |
|
||||||
session number | 1 | ||||||
tabling member constituency | Gravesham | ||||||
tabling member printed |
|
||||||
title | House of Commons Tabled Parliamentary Question 2017/19 280999 | ||||||
type |
|
||||||
uin | 280999 | ||||||
version | 1 | ||||||
written parliamentary question type | Ordinary | ||||||
answer | answer | ||||||
creator | 1522 | ||||||
publisher | 25259 | ||||||
tabling member | 1522 |